New drug trial offers hope for advanced lung cancer patients
NCT ID NCT07489716
Summary
This study is testing an experimental drug called SHR-1826 for people with advanced non-small cell lung cancer that has spread or can't be removed by surgery. About 90 participants who have already tried other treatments will receive the drug through an IV every three weeks. Researchers will measure how well the drug shrinks tumors, how long the response lasts, and what side effects occur.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Cancer Hospital of Shandong First Medical University
Jinan, Shandong, 250117, China
Contact
Conditions
Explore the condition pages connected to this study.